Horizon Therapeutics plc
- Home
- Companies
- Horizon Therapeutics plc
- Products
- Arrowhead - Uncontrolled Gout
Arrowhead - Uncontrolled Gout
Exclusive collaboration to investigate a short interfering RNA (siRNA) therapeutic targeting xanthine dehydrogenase in the liver (GalNAc) to reduce serum uric acid and treat uncontrolled gout.